MK0767 and Metformin Combination Study (0767-028)
NCT00543738
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
114
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
MK0767
Sponsor
Merck Sharp & Dohme LLC